The global neurostimulation devices market is experiencing substantial growth, driven by advancements in technology and an increasing prevalence of neurological disorders. The market size is projected to expand from USD 11.1 billion in 2022 to USD 36.5 billion by 2032, growing at a compound annual growth rate (CAGR).
While devices that stimulate the brain invasively have generally been available since 2002, and devices that do so non-invasively have been available since 2013, in recent years, the.
Bio-implants Market Projected size Garner Significant Revenues size 2025
BriefingWire.com, 5/10/2021 - Bio-implants are bioengineered products made up of biosynthetic materials such as collagen and tissue-engineered products like artificial skin and tissue. Bio-implants are used in organ transplantation and replacement of tissues.Bio-implants find application in cardiovascular, orthopedic, neurological, dental, and other areas. The global bio-implants market was 81.6 billion USD in 2018 and will reach 150.51 billion USD by 2025 at a CAGR of 9.14% during the period.
Growth by Region
North America will have the largest market by the end of the forecast period due to strong healthcare infrastructure, growing aging population and increasing prevalence of chronic diseases. Europe will also have major share in the market due to rising technological advancements and high geriatric population. On the other hand, Asia â Pacific will show significa